teensexonline.com

Lixte Biotechnology Holdings Says Combination Therapy Kills Cancer Cells in Animals; Shares Soar

Date:


MT Newswires 2023

All news about LIXTE BIOTECHNOLOGY HOLDINGS, INC.
01:27p Lixte Biotechnology Holdings Says Combination Therapy Kills Cancer Cells in Animals; Sh..

MT

12:17p Lixte biotechnology holdings, inc. reports that its lead clinical compound, lb-100, can..

AQ

01/23 Lixte Biotechnology : Investor Fact Sheet – January 2023

PU

2022 Lixte Biotechnology : Other Items – Form 8-K

PU

2022 Lixte Biotechnology Holdings, Inc. : Other Events (form 8-K)

AQ

2022 Stocks Remain Relatively Flat as Investors Wait for Fed Rate-Hike Move

MT

2022 Lixte Biotechnology Holdings, Inc. : Regulation FD Disclosure, Financial Statements and Ex..

AQ

2022 Lixte Biotechnology Holdings, Inc. : Regulation FD Disclosure, Financial Statements and Ex..

AQ

2022 Lixte Biotechnology Holdings, Inc. : Change in Directors or Principal Officers, Amendments..

AQ

2022 Lixte Biotechnology Holdings, Inc. Promotes Eric Forman to Vice President and Chief Ope..

CI

Sales 2021

Net income 2021 -6,73 M

Net cash 2021 4,82 M

P/E ratio 2021 -2,38x
Yield 2021
Capitalization 13,5 M
13,5 M
EV / Sales 2020
EV / Sales 2021
Nbr of Employees 4
Free-Float 45,4%

Chart LIXTE BIOTECHNOLOGY HOLDINGS, INC.



Duration :


Period :




Lixte Biotechnology Holdings, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Short Term Mid-Term Long Term
Trends Bullish Neutral Bearish

Income Statement Evolution


Share post:

Subscribe

Popular

More like this
Related